Feature | Patients |
Gender, n (%) | |
Male | 14 (44) |
Female | 18 (56) |
Age (years) | |
All patients, median (range) | 51.5 (18–65) |
Male patients, median (range) | 55.5 (33–65) |
Female patients, median (range) | 49 (18–64) |
Involved eye, n (%) | |
Right | 17 (53) |
Left | 15 (47) |
Associated systemic findings, n | |
HTN | 7 |
DM | 2 |
Moyamoya | 1 |
Aortic aneurysm | 1 |
Lipoma | 1 |
Visual acuity, n (%) | |
20/20 | 16 (50) |
20/40, below 20/20 | 16 (50) |
Below 20/40 | 0 (0) |
BVN formation, n (%) | |
Complete | 16 (50) |
Incomplete | 16 (50) |
Associated ocular findings, n in complete/n in incomplete BVN group | |
Optic disc oedema | 4/7 |
Peripapillary subretinal fluid | 0/3 |
Exudates | 3/5 |
RVO | 0/0 |
Hypofluorescence on FA, n in complete/n in incomplete BVN group | 3/12 |
Leakage through vessels within the tumour, n in complete/n in incomplete BVN group | 5/8 |
Tumour thickness (mm) | |
All patients, mean±SD (range) | 1.19±0.47 (0.37–2.21) |
Incomplete BVN group, mean±SD (range) | 1.44±0.42 (0.70–2.21) |
Complete BVN group, mean±SD (range) | 0.94±0.38 (0.37–1.50) |
BVN, blood vessel network; DM, diabetes mellitus; FA, fluorescein angiography; HTN, hypertension; RVO, retinal vein obstruction.